Fibromuscular dysplasia: Difference between revisions

	Fibromuscular dysplasia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Fibromuscular dysplasia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiorgram
X-ray
CT
MRI
Arteriography
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Management Guidelines
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
ASA/ACCF/AHA Guideline Recommendations
Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries
Case Studies
Case #1
Fibromuscular dysplasia On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Fibromuscular dysplasia All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Fibromuscular dysplasia
CDC on Fibromuscular dysplasia
Fibromuscular dysplasia in the news
Blogs on Fibromuscular dysplasia
Directions to Hospitals Treating Fibromuscular dysplasia
Risk calculators and risk factors for Fibromuscular dysplasia

Revision as of 15:30, 11 June 2018

For patient information page, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-in-Chief: Mohsen Basiri M.D.

Synonyms and keywords: FMD

@@ Line 9: / Line 9: @@
 == [[Fibromuscular dysplasia overview|Overview]] ==
-The definition of Fibromuscular Dysplasia(FMD) on the [[Medical Subject Headings]] is "an idiopathic, segmental, nonatheromatous disease of the musculature of arterial walls, leading to stenosis of small and medium-sized arteries. There is a true proliferation of smooth muscle cells and fibrous tissue. however, this systemic arteriopathy is a noninflammatory process and is therefore not associated with inflammatory biomarkers.
-According to the definition, FMD is a condition which can involve every vascular bed in the body, therefore it can cause very heterogeneous and extensive spectrum of clinical manifestations from asymptomatic involvement to devastating consequences and morbidity and mortality.
-Unlike routine conception that FMD is a disease of middle-age female, current data from the French and US registries showed that irrespective of age and sex, every practitioner at any level should be familiar with suggestive symptoms and signs of FMD and raise awareness about FMD which is more frequent and more often systematic than previously thought.
 == [[Fibromuscular dysplasia historical perspective|Historical Perspective]] ==